US EditionAnthropic Acquires Stealth Startup Coefficient Bio For $400 Million: Report
The pre-revenue startup’s 10-person team will join Anthropic as it builds specialized AI tools for biopharma research.
- Anthropic acquired Coefficient Bio in a stock deal valued at around $400 million, according to The Information on Thursday. The stealth biotech AI startup had operated with no publicly known product or disclosed revenue.
- Founded eight months ago, Coefficient Bio was led by Samuel Stanton and Nathan C. Frey, both former computational drug discovery leaders at Genentech's Prescient Design unit. The startup remained research-heavy and never left stealth mode.
- Approximately 10 researchers will join Anthropic's Health Care Life Sciences group, led by Eric Kauderer-Abrams. The team brings domain expertise in protein design and biomolecule modelling to integrate into Claude.
- Google DeepMind, Nvidia, and OpenAI are pursuing parallel drug discovery initiatives, intensifying competition for embedded AI in pharmaceutical workflows. Anthropic aims to capture recurring revenue by dominating life sciences research tools.
- Dimension is reportedly raising a $700 million fund while Breakout Ventures closed a $114 million fund in March, both targeting AI-biology crossovers. This reflects investor conviction that agentic AI will reshape life sciences as forcefully as it has software engineering.
14 Articles
14 Articles
Anthropic Acquires Stealth Startup Coefficient Bio For $400 Million: Report
Anthropic has reportedly acquired stealth AI biology startup Coefficient Bio in an all-stock deal worth just over $400 million, as the AI startup behind the Claude chatbot eyes a potential IPO as early as October. The acquisition was confirmed on Friday through a letter obtained by Newcomer. A Moonshot For Science Coefficient Bio was founded in September 2025 by Nathan Frey and Samuel Stanton, both formerly of Genentech's Prescient Design unit. …
Anthropic acquires biotech AI startup Coefficient Bio for $400 million
Anthropic has acquired Coefficient Bio, a stealth biotech startup with fewer than 10 people, for $400 million in stock. The former Genentech researchers join Anthropic's life sciences push.
Anthropic acquires AI biotech startup Coefficient Bio for $400M to expand into drug discovery and clinical workflows - Tech Startups
Anthropic is making a decisive move into biotech. The AI company has acquired Coefficient Bio, a young AI startup focused on applying AI to drug development and clinical strategy, in a deal valued at roughly $400 million, according to an […] The post Anthropic acquires AI biotech startup Coefficient Bio for $400M to expand into drug discovery and clinical workflows first appeared on Tech Startups.
Strategic Expansion: Anthropic Acquires Biotech AI Startup Coefficient Bio In $400M Deal
BitcoinWorld Strategic Expansion: Anthropic Acquires Biotech AI Startup Coefficient Bio in $400M Deal In a significant move that underscores the accelerating convergence of artificial intelligence and biotechnology, Anthropic has reportedly acquired stealth startup Coefficient Bio in a $400 million stock transaction, according to multiple industry reports confirmed on April 3, 2026. This strategic acquisition represents Anthropic’s most substant…
Coverage Details
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
